Pages

Saturday, January 2, 2016

Genetic research can catch risk of disease

... gained momentum much faster than company officials expected. In January 2014, Geisinger and research partner, the Tarrytown, New York-based Regeneron Pharmaceuticals, set out to sequence 100,000 human exomes - the protein-rich portion of the genome ...
http://ift.tt/1YXgIvv

No comments:

Post a Comment